Literature DB >> 29300869

Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study.

Bernard Iung1, Victoria Delgado2, Patrice Lazure3, Suzanne Murray3, Per Anton Sirnes4, Raphael Rosenhek5, Susanna Price6, Marco Metra7, Céline Carrera8, Michele De Bonis9, Michael Haude10, Gerhard Hindricks11, Jeroen Bax2, Alec Vahanian1.   

Abstract

Aims: To assess the knowledge and application of European Society of Cardiology (ESC) Guidelines in the management of mitral regurgitation (MR). Methods and results: A mixed-methods educational needs assessment was performed. Following a qualitative phase (interviews), an online survey was undertaken using three case scenarios (asymptomatic severe primary MR, symptomatic severe primary MR in the elderly, and severe secondary MR) in 115 primary care physicians (PCPs), and 439 cardiologists or cardiac surgeons from seven European countries. Systematic cardiac auscultation was performed by only 54% of clinicians in asymptomatic patients. Cardiologists appropriately interpreted echocardiographic assessment of mechanism and quantification of primary MR (≥75%), but only 44% recognized secondary MR as severe. In asymptomatic severe primary MR with an indication for surgery, 27% of PCPs did not refer the patient to a cardiologist and medical therapy was overused by 19% of cardiologists. In the elderly patient with severe symptomatic primary MR, 72% of cardiologists considered mitral intervention (transcatheter edge-to-edge valve repair in 72%). In severe symptomatic secondary MR, optimization of medical therapy was advised by only 51% of PCPs and 33% of cardiologists, and surgery considered in 30% of cases (transcatheter edge-to-edge repair in 64%).
Conclusion: Systematic auscultation is underused by PCPs for the early detection of MR. Medical therapy is overused in primary MR and underused in secondary MR. Indications for interventions are appropriate in most patients with primary MR, but are unexpectedly frequent for secondary MR. These gaps identify important targets for future educational programs.

Entities:  

Mesh:

Year:  2018        PMID: 29300869     DOI: 10.1093/eurheartj/ehx763

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

1.  "Guidelines Recommendations on the Treatment of Tricuspid Regurgitation. Where Are We and Where Do We Go With Transcatheter Valve Intervention".

Authors:  Alec Vahanian; Eric Brochet; Jean-Michel Juliard
Journal:  Front Cardiovasc Med       Date:  2018-04-12

2.  Characterizing mitral regurgitation in a contemporary population: prognostic implications.

Authors:  Victoria Delgado; Nina Ajmone Marsan; Jeroen J Bax
Journal:  Eur Heart J       Date:  2019-07-14       Impact factor: 29.983

Review 3.  EDUCATIONAL SERIES ON THE SPECIALIST VALVE CLINIC: Challenges in the diagnosis and management of valve disease: the case for the specialist valve clinic.

Authors:  David Messika-Zeitoun; Ian G Burwash; Thierry Mesana
Journal:  Echo Res Pract       Date:  2019-12-01

4.  The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.

Authors:  Andrew J S Coats; Stefan D Anker; Andreas Baumbach; Ottavio Alfieri; Ralph Stephan von Bardeleben; Johann Bauersachs; Jeroen J Bax; Serge Boveda; Jelena Čelutkienė; John G Cleland; Nikolaos Dagres; Thomas Deneke; Dimitrios Farmakis; Gerasimos Filippatos; Jörg Hausleiter; Gerhard Hindricks; Ewa A Jankowska; Mitja Lainscak; Christoph Leclercq; Lars H Lund; Theresa McDonagh; Mandeep R Mehra; Marco Metra; Nathan Mewton; Christian Mueller; Wilfried Mullens; Claudio Muneretto; Jean-Francois Obadia; Piotr Ponikowski; Fabien Praz; Volker Rudolph; Frank Ruschitzka; Alec Vahanian; Stephan Windecker; Jose Luis Zamorano; Thor Edvardsen; Hein Heidbuchel; Petar M Seferovic; Bernard Prendergast
Journal:  Eur Heart J       Date:  2021-03-18       Impact factor: 29.983

5.  Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank.

Authors:  Monica Tung; Gregory Nah; Janet Tang; Greg Marcus; Francesca N Delling
Journal:  Open Heart       Date:  2022-09

6.  Presentation and outcomes of mitral valve surgery in France in the recent era: a nationwide perspective.

Authors:  David Messika-Zeitoun; Pascal Candolfi; Maurice Enriquez-Sarano; Ian G Burwash; Vincent Chan; Jean-Francois Philippon; Jean-Manuel Toussaint; Partrick Verta; Ted E Feldman; Bernard Iung; David Glineur; Jean-Francois Obadia; Alec Vahanian; Thierry Mesana
Journal:  Open Heart       Date:  2020-08

7.  Individual patient data meta-analysis of the effects of the CARILLON® mitral contour system.

Authors:  Francesco Giallauria; Anna Di Lorenzo; Alessandro Parlato; Crescenzo Testa; Emanuele Bobbio; Carlo Vigorito; Andrew J Stewart Coats
Journal:  ESC Heart Fail       Date:  2020-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.